Biomed Central Ltd

SHERPA: Unknown

People

  1. Abou-Alfa
    Abou-Alfa
  2. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (8)
  2. Gastrointestinal Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Center for Pancreatic Cancer Research (1)
  5. Epidemiology Service (1)
  6. Epidemiology and Biostatistics (1)
Search Within
  1. "Ghassan Abou-Alfa"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
  3. Guidelines (1)
Groups
  1. Department of Medicine (8)
  2. Gastrointestinal Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Center for Pancreatic Cancer Research (1)
  5. Epidemiology Service (1)
  6. Epidemiology and Biostatistics (1)
People
  1. Ghassan Abou-Alfa (8)
  2. Eileen O'Reilly (1)
  3. Sara Olson (1)
Years
  1. 2022 (4)
  2. 2021 (1)
  3. 2017 (1)
  4. 2013 (1)
  5. 2012 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (4)
  2. BMC Cancer (2)
  3. World Journal of Surgical Oncology (2)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in "cold" and I-O refractory metastatic solid tumors
    Meeting Abstract

    Wilky, B.; El-Khoueiry, A.; Bullock, A.; Tsimberidou, A.; Mahadevan, D.; Margolin, K.; Trent, J.; Bockorny, B.; Moser, J.; Hosein, P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immunogenicity of durvalumab: Analysis of pooled pan-tumor data
    Meeting Abstract

    El-Khoueiry, A.; Zhou, D.; Ozguroglu, M.; Johnson, M.; Abou-Alfa, G.; Makowsky, M.; Krug, L.; Gupta, A.; Chen, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Characteristics of the tumor microenvironment in IDH1-mutated cholangiocarcinoma patients from ClarIDHy trial
    Meeting Abstract

    Saatcioglu, H. D.; Valle, J.; Macarulla, T.; Javle, M.; Oh, D. Y.; Goyal, L.; Conway, J.; Iyer, J.; Najdawi, F.; Shah, C.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
    Journal Article

    El-Khoueiry, A. B.; Meyer, T.; Cheng, A. L.; Rimassa, L.; Sen, S.; Milwee, S.; Kelley, R. K.; Abou-Alfa, G. K.
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
    Guidelines

    Greten, T. F.; Abou-Alfa, G. K.; Cheng, A. L.; Duffy, A. G.; El-Khoueiry, A. B.; Finn, R. S.; Galle, P. R.; Goyal, L.; He, A. R.; Kaseb, A. O.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Proportion of cancer in a Middle eastern country attributable to established risk factors
    Journal Article

    Charafeddine, M. A.; Olson, S. H.; Mukherji, D.; Temraz, S. N.; Abou-Alfa, G. K.; Shamseddine, A. I.
    BMC Cancer (2017)

    Fulltext@MSK | Save
  • Postoperative outcomes following pancreaticoduodenectomy: How should age affect clinical practice?
    Journal Article

    Faraj, W.; Alameddine, R.; Mukherji, D.; Musallam, K.; Haydar, A.; Eloubiedi, M.; Shamseddine, A.; Halal, A.; Abou-Alfa, G. K.; O'Reilly, E. M.; more...
    World Journal of Surgical Oncology (2013)

    Fulltext@MSK | Save
  • Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: A retrospective study from the Middle East
    Journal Article

    Elias, E.; Mukherji, D.; Faraj, W.; Khalife, M.; Dimassi, H.; Eloubeidi, M.; Hattoum, H.; Abou-Alfa, G. K.; Saleh, A.; Shamseddine, A.
    World Journal of Surgical Oncology (2012)

    Fulltext@MSK | Save